Product Images Mirabegron
View Photos of Packaging, Labels & Appearance
- structure - fe06b979 134e 4ba2 9f86 ab442a3562a1 01
- Figure 1 - fe06b979 134e 4ba2 9f86 ab442a3562a1 02
- Figure 2 - fe06b979 134e 4ba2 9f86 ab442a3562a1 03
- Figure 3 - fe06b979 134e 4ba2 9f86 ab442a3562a1 04
- Figure 4 - fe06b979 134e 4ba2 9f86 ab442a3562a1 05
- Figure 5 - fe06b979 134e 4ba2 9f86 ab442a3562a1 06
- Figure 6 - fe06b979 134e 4ba2 9f86 ab442a3562a1 07
- Figure 7 - fe06b979 134e 4ba2 9f86 ab442a3562a1 08
- Figure 8 - fe06b979 134e 4ba2 9f86 ab442a3562a1 09
- Mirabegron extended-release tablets, 25mg - fe06b979 134e 4ba2 9f86 ab442a3562a1 10
- Mirabegron extended-release tablets, 50mg - fe06b979 134e 4ba2 9f86 ab442a3562a1 11
Product Label Images
The following 11 images provide visual information about the product associated with Mirabegron NDC 70710-1159 by Zydus Pharmaceuticals (usa) Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structure - fe06b979 134e 4ba2 9f86 ab442a3562a1 01
Figure 1 - fe06b979 134e 4ba2 9f86 ab442a3562a1 02
Figure 2 - fe06b979 134e 4ba2 9f86 ab442a3562a1 03
Figure 3 - fe06b979 134e 4ba2 9f86 ab442a3562a1 04
Figure 4 - fe06b979 134e 4ba2 9f86 ab442a3562a1 05
Figure 5 - fe06b979 134e 4ba2 9f86 ab442a3562a1 06
Figure 6 - fe06b979 134e 4ba2 9f86 ab442a3562a1 07
Mean Change from Baseline: - Placebo group (n=433) - Week - Mirabegron 50 mg group (n=425)*
Figure 7 - fe06b979 134e 4ba2 9f86 ab442a3562a1 08
This text appears to be a table showing the mean change from baseline for a certain variable. The values range from 0.00 to -2.00, with increments of -0.25. The table also includes a value of =175, which could be a reference to a specific calculation or result. Additionally, there are mentions of "mirabegron" in different dosages (25 mg and 50 mg), along with corresponding sample sizes (n=254 and n=257). The rest of the text is either unclear or irrelevant.*
Figure 8 - fe06b979 134e 4ba2 9f86 ab442a3562a1 09
Mirabegron extended-release tablets, 25mg - fe06b979 134e 4ba2 9f86 ab442a3562a1 10
Mirabegron extended-release tablets, 50mg - fe06b979 134e 4ba2 9f86 ab442a3562a1 11
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
